Clinical Trial Update: H01 in Adults With Interstitial Lung Disease (The SOLIS Study) [Phase 2]

View source ↗

Summary

The SOLIS study is a Phase 2 clinical trial sponsored by NIEHS evaluating H01 in adults with interstitial lung disease, including idiopathic pulmonary fibrosis.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease

Snippet

Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Conditions: Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis | Phase 2 | Status: RECRUITING